IBS Management: Finding Relief by Breaking the Cycle
Irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) are highly prevalent gastrointestinal disorders, associated with a major impact on patient quality of life, work productivity and healthcare costs.
This program will encourage clinicians to play a greater role in recognizing and diagnosing chronic idiopathic constipation (CIC), constipation-predominant IBS (IBS-C), and diarrhea-predominant IBS (IBS-D) within their practice, and to optimize IBS management with appropriate treatment options. It will also encourage clinicians to recognize the need for timely escalation of treatment in people who continue to have symptoms despite the use of OTC medications.
This program has received an educational grant or in-kind support from Allergan.
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 1 Mainpro+ credits
Louis Liu, MD, PhD, FRCPC, CAGF
Julia Pottinger, BSc MD CCFP
Kristin Terenzi, BSc. (Hon), MD, FCFP
Albert Ng, MD, MCFP(COE), ICD.D
Upon completion of this program, participants will be better able to:
- Identify patients who have chronic idiopathic constipation (CIC) and irritable bowel syndrome (IBS)
- Implement guideline recommendations into practice to ensure effective management of patients with CIC or IBS
- Apply appropriate treatment escalation strategies for patients with inadequately controlled CIC or IBS